Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | December 24, 2013 |
| Target | Pinnacle Biologics |
| Sector | Life Science |
| Buyer(s) | ADVANZ PHARMA |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Torreya Partners (Financial) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1963 |
| Sector | Life Science |
| Employees | 675 |
| Revenue | 508M USD (2019) |
ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines with direct sales access in Europe and a global distribution network. ADVANZ PHARMA was founded in 1963 and is based in London, United Kingdom.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 6 |
| Sector: Life Science | 1 of 4 |
| Type: Add-on Acquisition | 1 of 3 |
| State: Illinois | 1 of 1 |
| Country: United States | 1 of 3 |
| Year: 2013 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-03-20 |
Donnatal
United States Donnatal provides Donnatal, an adjunctive therapy in the treatment of irritable bowel syndrome ("IBS") and acute enterocolitis. It comes in two formulations: immediate release Donnatal Tablets, and immediate release Donnatal Elixir, a liquid. |
Buy | $200M |
